CRDL
Goldman Sachs’s Cardiol Therapeutics CRDL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $78.2K | Buy |
57,500
+18,300
| +47% | +$24.9K | ﹤0.01% | 4928 |
|
|
2025
Q1 | $38K | Buy |
39,200
+3,300
| +9% | +$3.2K | ﹤0.01% | 4943 |
|
|
2024
Q4 | $46K | Sell |
35,900
-200
| -0.6% | -$256 | ﹤0.01% | 4857 |
|
|
2024
Q3 | $71.5K | Buy |
36,100
+12,600
| +54% | +$24.9K | ﹤0.01% | 4639 |
|
|
2024
Q2 | $47.5K | Hold |
23,500
| – | – | ﹤0.01% | 4568 |
|
|
2024
Q1 | $42.5K | Hold |
23,500
| – | – | ﹤0.01% | 4551 |
|
|
2023
Q4 | $19.8K | Hold |
23,500
| – | – | ﹤0.01% | 4610 |
|
|
2023
Q3 | $21K | Hold |
23,500
| – | – | ﹤0.01% | 4562 |
|
|
2023
Q2 | $20.9K | Sell |
23,500
-1,100
| -4% | -$979 | ﹤0.01% | 4750 |
|
|
2023
Q1 | $12K | Sell |
24,600
-76,900
| -76% | -$37.5K | ﹤0.01% | 4937 |
|
|
2022
Q4 | $51.8K | Buy |
+101,500
| New | +$51.8K | ﹤0.01% | 4784 |
|
|
2022
Q2 | – | Sell |
-65,600
| Closed | -$100K | – | 5714 |
|
|
2022
Q1 | $100K | Sell |
65,600
-60,500
| -48% | -$92.2K | ﹤0.01% | 5313 |
|
|
2021
Q4 | $233K | Buy |
126,100
+107,000
| +560% | +$198K | ﹤0.01% | 4911 |
|
|
2021
Q3 | $79K | Buy |
+19,100
| New | +$79K | ﹤0.01% | 5095 |
|